PTCT Stock Summary and Trading Ideas (PTC Therapeutics | NASDAQ:PTCT)

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

What symbol and exchange does PTC Therapeutics shares trade?

PTC Therapeutics trades on the NASDAQ stock market under the symbol PTCT.

What is PTC Therapeutics stock price doing today?

As of February 20, 2026, PTCT stock price climbed to $70.66 with 2,382,563 million shares trading.

What is PTC Therapeutics's Beta?

PTCT has a beta of 0.87, meaning it tends to be less sensitive to market movements. PTCT has a correlation of 0.09 to the broad based SPY ETF.

How much is PTC Therapeutics worth?

PTCT has a market cap of $5.67 billion. This is considered a Mid Cap stock.

How much money does PTC Therapeutics make?

Last quarter PTC Therapeutics reported $165 million in Revenue and -$1.67 earnings per share. This fell short of revenue expectation by $-131 million and missed earnings estimates by -$1.34.

What is the highest and lowest price PTC Therapeutics traded in the last 3 year period?

In the last 3 years, PTCT traded as high as $87.50 and as low as $17.53.

What are the top ETFs holding PTC Therapeutics?

The top ETF exchange traded funds that PTCT belongs to (by Net Assets): IJR, VTI, VB, IWM, XBI.

Is PTC Therapeutics (PTCT) a good investment?

PTCT has outperformed the market in the last year with a return of +40.3%, while the SPY ETF gained +14.1%. However, in the most recent history, PTCT shares have underperformed the stock market with its stock returning -7.6% in the last 3 month period and -5.4% for the last 2 week period, while SPY has returned +6.0% and -0.2%, respectively.

What are the support and resistance levels for PTC Therapeutics (PTCT)?

PTCT support price is $68.38 and resistance is $71.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PTCT shares will trade within this expected range on the day.